Puncture Breast Abscess (PONCTABCESEIN)

Continuation of Breastfeeding After Management of Breast Abscesses by Ultrasound-guided Punctures

Several breast diseases can complicate breastfeeding : 4% of women develop a mastitis and 1% develop an abscess.

The study deals with cases of breast abscess that have been treated according to a defined protocol (Parisian Perinatal Health Network), by a multidisciplinary team (center of Medical Imaging Duroc) trained in breastfeeding and ultrasound-guided punctures.

The aim of the study is to define the risk factors for the onset of a breast abscess, to evaluate the indications and methods of management of abscess by ultrasound puncture, and to provide arguments motivating the continuation of breastfeeding.

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75015
        • AP-HP Hopital Necker Enfants malades

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Women punctured for a breast lactant abscess in the center of Medical Imaging Duroc

Description

Inclusion Criteria:

  • Nursing mothers
  • Patients referred for breast abscesses during lactation
  • Having an abscess confirmed ultrasoundly and indicating a puncture
  • Women punctured of an abscess of the breast abscess in the center of Medical Imaging Duroc
  • Not opposing the use of them given and to answer the questionnaire on the immediate and medium-term future by telephone
  • Women aged > 18 years old
  • Women understanding French
  • Affiliated to Social Security

Exclusion Criteria:

No

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Continuation of breastfeeding
Time Frame: 1 week to 6 months after the puncture
Phone call to the patient
1 week to 6 months after the puncture

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Etiology of the abscess
Time Frame: 1 week to 6 months after the puncture
Medical record and phone call to the patient
1 week to 6 months after the puncture
Adequacy of medical care with the protocol of the Parisian Perinatal Health Network
Time Frame: 1 week to 6 months after the puncture
Medical record and phone call to the patient
1 week to 6 months after the puncture
Relationship between puncture breastfeeding continuation
Time Frame: 1 week to 6 months after the puncture
Medical record and phone call to the patient
1 week to 6 months after the puncture
Relationship between surgery and weaning
Time Frame: 1 week to 6 months after the puncture
Medical record and phone call to the patient
1 week to 6 months after the puncture

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Virginie Rigourd, MD, Assistance Publique - Hôpitaux de Paris

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

December 1, 2018

Primary Completion (Anticipated)

December 1, 2018

Study Completion (Anticipated)

December 1, 2018

Study Registration Dates

First Submitted

November 2, 2018

First Submitted That Met QC Criteria

November 2, 2018

First Posted (Actual)

November 5, 2018

Study Record Updates

Last Update Posted (Actual)

June 30, 2021

Last Update Submitted That Met QC Criteria

June 26, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • APHP18022
  • 2018-A02069-46 (Registry Identifier: ID RCB)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Abscess

Clinical Trials on Phone call to the patient

3
Subscribe